Vantage Investment Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-163,175
Closed -$7.97M 95
2018
Q2
$7.97M Sell
163,175
-3,168
-2% -$180K 0.58% 54
2018
Q1
$10.4M Buy
166,343
+121,474
+271% +$8.33M 0.86% 42
2017
Q4
$2.75M Sell
44,869
-117,301
-72% -$7.25M 0.25% 58
2017
Q3
$10.9M Buy
162,170
+987
+0.6% +$69.8K 0.85% 41
2017
Q2
$12.6M Buy
161,183
+30,476
+23% +$2.3M 1.14% 20
2017
Q1
$10.7M Buy
130,707
+104,364
+396% +$8.21M 1.19% 32
2016
Q4
$1.9M Sell
26,343
-131,177
-83% -$9.48M 0.25% 39
2016
Q3
$12.2M Buy
157,520
+5,534
+4% +$447K 1.58% 20
2016
Q2
$11.9M Buy
+151,986
New +$12.1M 1.24% 26

Other funds holding CAH

Vantage Investment Partners's CAH Position: Q3 2018 in Review

Vantage Investment Partners sold out of Cardinal Health (CAH) in Q3 2018, closing a stake of 163,175 shares — an estimated $7.97M sold.

Vantage Investment Partners first reported a position in CAH in Q2 2016 and held it in 9 quarters. The position peaked at $12.6M in Q2 2017. 685 funds tracked by Wall St. Rank hold CAH as of Q3 2018.

  • Vantage Investment Partners reported no remaining Cardinal Health position as of Q3 2018 after selling out during the quarter.
  • Vantage Investment Partners sold 163,175 Cardinal Health shares in Q3 2018, an estimated $7.97M.
  • Vantage Investment Partners first reported a position in Cardinal Health in Q2 2016 and held it in 9 quarters.
  • Vantage Investment Partners's Cardinal Health position peaked at $12.6M in Q2 2017.
  • 685 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2018.

Based on Vantage Investment Partners's 13F filing for Q3 2018, filed 31 Oct 2018.